Lexaria Bioscience (LEXX) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for Lexaria Bioscience (LEXX) over the last 15 years, with Q4 2025 value amounting to -$984098.0.
- Lexaria Bioscience's Free Cash Flow rose 6422.36% to -$984098.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$8.7 million, marking a year-over-year decrease of 3252.73%. This contributed to the annual value of -$10.5 million for FY2025, which is 10941.62% down from last year.
- Lexaria Bioscience's Free Cash Flow amounted to -$984098.0 in Q4 2025, which was up 6422.36% from -$2.6 million recorded in Q3 2025.
- In the past 5 years, Lexaria Bioscience's Free Cash Flow registered a high of -$619614.0 during Q1 2024, and its lowest value of -$3.6 million during Q2 2025.
- In the last 5 years, Lexaria Bioscience's Free Cash Flow had a median value of -$1.3 million in 2022 and averaged -$1.5 million.
- The largest annual percentage gain for Lexaria Bioscience's Free Cash Flow in the last 5 years was 6422.36% (2025), contrasted with its biggest fall of 18307.54% (2025).
- Over the past 5 years, Lexaria Bioscience's Free Cash Flow (Quarter) stood at -$1.2 million in 2021, then dropped by 4.73% to -$1.3 million in 2022, then grew by 6.65% to -$1.2 million in 2023, then tumbled by 132.78% to -$2.8 million in 2024, then surged by 64.22% to -$984098.0 in 2025.
- Its Free Cash Flow was -$984098.0 in Q4 2025, compared to -$2.6 million in Q3 2025 and -$3.6 million in Q2 2025.